Origins and relatedness of human leukocyte antigen class I allele supertypes

Human Immunology

Volumn 71, Issue 9, 2010, Pages 837-842

  Naugler, Christopher ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

Author keywords

Allele supertype; Evolution; HLA alleles; Phylogeny

Indexed keywords

HLA A ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CLADISTICS; CONVERGENT EVOLUTION; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

ALLELES; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BINDING SITES; DATABASES, NUCLEIC ACID; EVOLUTION, MOLECULAR; EXONS; GENES, MHC CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; PHYLOGENY; SELECTION, GENETIC; SEQUENCE ALIGNMENT;

EID: 77956011703     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.06.010     Document Type: Article

References (29)

1. Schwensow N., Fietz J., Dausmann K.H., Sommer S. Neutral versus adaptive genetic variation in parasite resistance: Importance of MHC-supertypes in a free-ranging primate. Heredity 2007, 99:265-277.
2. Hughes A.L., Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988, 335:167-170.
3. Hughes A.L., Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998, 32:415-435.
4. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I supertypes: A revised and updated classification. BMC Immunol 2008, 9:1.
5. Sidney J., Southwood S., Mann D.L., Fernandez-Vina M.A., Neuman M.J., Sette A. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 2001, 62:1200-1216.
6. Khanma R., Burrows S.R., Nichols J., Poulsen L.M. Identification of cytotoxic T-cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA-A2 supertype-restricted immune recognition of EBV infected cells by LMP1-specific cytotoxic T lymphocytes. Eur J Immunol 1998, 28:451-458.
7. Lyke K.E., Burges R.B., Cissoko Y., Sangare L., Kone A., Dao M., et al. HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls. Infect Immun 2005, 73:5799-5808.
8. Taylor G.M., Richards S., et al. Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: Evidence for selective loss of immunological control of residual disease?. Br J Haematol 2009, 145:87-95.
9. Taylor M., Harrison C., Eden T., Birch J., Greaves M., Lightfoot T., et al. HLA-DPB1 supertype-associated protectio from childhood leukaemia: Relationship to leukemia karyotype and implications for prevention. Cancer Immunol Immunother 2008, 57:53-61.
10. Trachenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003, 9:928-935.
11. MacDonald K.S., Embree J.E., et al. The HLAA2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001, 183:503-506.
12. MacDonald K.S., Fowke K.R., Kimani J., Dunand V.A., Nagelkerke N.J., Ball T.B., et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000, 181:1581-1589.
13. Sette A., Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999, 50:201-212.
14. Sette A., Sidney J., Livingston B.D., Dzuris J.L., Crimi C., Walker C.M., et al. I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution. Immunogenetics 2003, 54:830-841.
15. MacDonald K.S., Matukas L., Embree J.E., Fowke K., Kimani J., Nagelkerke N.J., et al. Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 2001, 79:151-157.
16. Matsueda S., Takedatsu H., Yao A., Tanaka M., Noguchi M., Itoh K., Harada M. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles. Clin Cancer Res 2005, 11:6933-6943.
17. Matsueda S., Takedatsu H., Sasada T., Azuma K., Ishihara Y., Komohara Y., et al. New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles. J Immunother 2007, 30:274-281.
18. Naito M., Komohara Y., Ishihara Y., Noguchi M., Yamashita Y., Shirakusa T., et al. Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles. Br J Cancer 2007, 97:1648-1654.
19. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz V.S., Poland G.A. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: Findings and implications for vaccine design. Vaccine 2007, 25:3090-3100.
20. Ovsyannikova I.G., Vierkant R.A., et al. HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. Vaccine 2009, 27:3349-3358.
21. Lichterfeld M., Williams K.L., Mui S.K., Shah S.S., Mothe B.R., Sette A., et al. T cell receptor cross-recognition of an HIV-1;CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Int Immunol 2006, 18:1179-1188.
22. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
23. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
24. Maddison W.P., Maddison D.R. Mesquite: A modular system for evolutionary analysis, version 2.6 Last accessed 01 May 2010. http://mesquiteproject.org.
25. Saitou N., Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
26. Felsenstein J. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985, 39:783-791.
27. Cooke G.S., Hill A.V.S. Genetics of susceptibility to human infectious disease. Nat Rev 2001, 2:967-977.
28. Hughes A.L. Evolution of introns and exons of class II major histocompatibility complex genes of vertebrates. Immunogenetics 2000, 51:473-486.
29. Tamura K., Nei M., Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 2004, 101:11030-11035.